370 related articles for article (PubMed ID: 33133304)
1. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers.
Khalifa O; Errafii K; Al-Akl NS; Arredouani A
Dis Markers; 2020; 2020():8822859. PubMed ID: 33133304
[TBL] [Abstract][Full Text] [Related]
2. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease.
Zaiou M
World J Gastroenterol; 2022 Sep; 28(35):5111-5128. PubMed ID: 36188722
[TBL] [Abstract][Full Text] [Related]
3. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.
Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225
[TBL] [Abstract][Full Text] [Related]
4. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease.
Huang R; Duan X; Fan J; Li G; Wang B
Biomed Res Int; 2019; 2019():8690592. PubMed ID: 30931332
[TBL] [Abstract][Full Text] [Related]
5. The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review.
Shi N; Sun K; Tang H; Mao J
J Clin Lab Anal; 2023 Jun; 37(11-12):e24943. PubMed ID: 37435630
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review.
Zhang X; Asllanaj E; Amiri M; Portilla-Fernandez E; Bramer WM; Nano J; Voortman T; Pan Q; Ghanbari M
Eur J Clin Invest; 2021 May; 51(5):e13479. PubMed ID: 33350463
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment.
De Vincentis A; Rahmani Z; Muley M; Vespasiani-Gentilucci U; Ruggiero S; Zamani P; Jamialahmadi T; Sahebkar A
Drug Discov Today; 2020 Jul; 25(7):1277-1286. PubMed ID: 32439605
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.
Liu XL; Cao HX; Fan JG
J Dig Dis; 2016 Nov; 17(11):708-715. PubMed ID: 27628945
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.
Aggeletopoulou I; Kalafateli M; Tsounis EP; Triantos C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629043
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA in Non-alcoholic fatty liver disease.
Rohilla S; Kaur S; Puria R
Adv Clin Chem; 2022; 110():1-35. PubMed ID: 36210072
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
Fang Z; Dou G; Wang L
Int J Biol Sci; 2021; 17(7):1851-1863. PubMed ID: 33994867
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease.
Ashraf NU; Altaf M
Mutat Res Rev Mutat Res; 2018; 778():1-12. PubMed ID: 30454678
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.
Zaiou M
Cells; 2023 Apr; 12(8):. PubMed ID: 37190114
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases.
Zaiou M
Adv Exp Med Biol; 2019; 1134():177-191. PubMed ID: 30919338
[TBL] [Abstract][Full Text] [Related]
15. Genetics and epigenetics purpose in nonalcoholic fatty liver disease.
Botello-Manilla AE; Chávez-Tapia NC; Uribe M; Nuño-Lámbarri N
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):733-748. PubMed ID: 32552211
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).
Ota T
Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745
[TBL] [Abstract][Full Text] [Related]
18. The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?
Bartiromo M; Nardolillo M; Ferrara S; Russo G; Miraglia Del Giudice E; Di Sessa A
Expert Rev Gastroenterol Hepatol; 2023; 17(8):817-824. PubMed ID: 37497846
[TBL] [Abstract][Full Text] [Related]
19. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
Sun C; Fan JG; Qiao L
Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
